XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements Of Changes In Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Surplus [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Starting Balance at Dec. 31, 2021 $ 110,280 $ 8,556 $ 12,115 $ 89,764   $ (155)
Net income 3,250     3,250    
Other comprehensive income (loss) (10,628)         (10,628)
Vesting of restricted stock awards, stock incentive plan   31 (31)      
Stock-based compensation expense 195   195      
Issuance of common stock, dividend investment plan 97 7 90      
Repurchase and retirement of common stock (117) (8) (109)      
Dividends declared (974)     (974)    
End Balance at Mar. 31, 2022 102,103 8,586 12,260 92,040   (10,783)
Starting Balance at Dec. 31, 2021 110,280 8,556 12,115 89,764   (155)
Net income 11,324          
Other comprehensive income (loss) (21,076)          
End Balance at Sep. 30, 2022 98,500 8,600 13,003 98,128   (21,231)
Starting Balance at Mar. 31, 2022 102,103 8,586 12,260 92,040   (10,783)
Net income 3,992     3,992    
Other comprehensive income (loss) (5,973)         (5,973)
Stock-based compensation expense 222   222      
Issuance of common stock, employee benefit plan 120 8 112      
Dividends declared (974)     (974)    
End Balance at Jun. 30, 2022 99,490 8,594 12,594 95,058   (16,756)
Net income 4,082     4,082    
Other comprehensive income (loss) (4,475)         (4,475)
Stock-based compensation expense 329   329      
Issuance of common stock, dividend investment plan 101 7 94      
Issuance of common stock, employee benefit plan 22 2 20      
Repurchase and retirement of common stock (37) (3) (34)      
Dividends declared (1,012)     (1,012)    
End Balance at Sep. 30, 2022 98,500 8,600 13,003 98,128   (21,231)
Starting Balance at Dec. 31, 2022 101,729 8,629 13,268 100,278   (20,446)
Cumulative effect adjustment for CECL (1,961)       $ (1,961)  
Net income 2,585     2,585    
Other comprehensive income (loss) 2,975         2,975
Vesting of restricted stock awards, stock incentive plan   31 (31)      
Stock-based compensation expense 317   317      
Repurchase and retirement of common stock (128) (9) (119)      
Dividends declared (1,057)     (1,057)    
End Balance at Mar. 31, 2023 104,460 8,651 13,435 99,845   (17,471)
Starting Balance at Dec. 31, 2022 101,729 8,629 13,268 100,278   (20,446)
Net income 6,962          
Other comprehensive income (loss) (3,107)          
End Balance at Sep. 30, 2023 101,183 8,660 13,970 102,106   (23,553)
Starting Balance at Mar. 31, 2023 104,460 8,651 13,435 99,845   (17,471)
Net income 2,058     2,058    
Other comprehensive income (loss) (1,945)         (1,945)
Stock-based compensation expense 323   323      
Issuance of common stock, employee benefit plan 133 10 123      
Dividends declared (1,059)     (1,059)    
End Balance at Jun. 30, 2023 103,970 8,661 13,881 100,844   (19,416)
Net income 2,319     2,319    
Other comprehensive income (loss) (4,137)         (4,137)
Vesting of restricted stock awards, stock incentive plan   11 (11)      
Stock-based compensation expense 263   263      
Repurchase and retirement of common stock (175) (12) (163)      
Dividends declared (1,057)     (1,057)    
End Balance at Sep. 30, 2023 $ 101,183 $ 8,660 $ 13,970 $ 102,106   $ (23,553)